skip to main content
Show Results with:

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

PLoS One, May 2015, Vol.10(5), p.e0125954 [Peer Reviewed Journal]

Full text available

View all versions

Searching Remote Databases, Please Wait